Paula G Heller Selected Research

MYH9-Related Disorders

1/2016	Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
2/2014	MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.
1/2013	MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations.
12/2009	MYH9 related disease: a novel missense Ala95Asp mutation of the MYH9 gene.
3/2008	Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paula G Heller Research Topics

Disease

7	Essential Thrombocythemia 01/2020 - 02/2005
5	Hemorrhage 01/2021 - 08/2014
5	MYH9-Related Disorders 01/2016 - 03/2008
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019 - 06/2014
3	Inflammation (Inflammations) 01/2021 - 01/2019
3	Thrombocytopenia (Thrombopenia) 01/2019 - 06/2005
2	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 05/2010
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 06/2005
2	Neoplasms (Cancer) 12/2016 - 06/2005
1	Disease Progression 01/2021
1	Splenomegaly 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Thrombophilia 01/2019
1	Thrombosis (Thrombus) 12/2016
1	Anemia 04/2016
1	Hearing Loss (Hearing Impairment) 01/2016
1	Sensorineural Hearing Loss 01/2016
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 09/2014
1	Hyperplasia 01/2009
1	Thrombocytosis (Thrombocythemia) 08/2005
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2005
1	Moyamoya Disease (Moya-Moya Disease) 08/2005

Drug/Important Bio-Agent (IBA)

3	Hemostatics (Antihemorrhagics)IBA 01/2020 - 01/2017
3	Inosine Triphosphate (ITP)IBA 01/2019 - 06/2014
3	anagrelide (Agrylin)FDA LinkGeneric 04/2016 - 02/2005
3	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2016 - 03/2008
3	Nonmuscle Myosin Type IIAIBA 01/2013 - 03/2008
2	AutoantibodiesIBA 01/2021 - 10/2018
2	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2017 - 01/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2021
1	LipopolysaccharidesIBA 01/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	LigandsIBA 01/2020
1	Collagen ReceptorsIBA 01/2019
1	CytokinesIBA 01/2019
1	Extracellular Matrix ProteinsIBA 10/2018
1	Nucleosomes (Nucleosome)IBA 12/2016
1	AntibodiesIBA 01/2016
1	Amino Acids FDA Link 01/2016
1	von Willebrand FactorIBA 09/2014
1	Interleukin-6 (Interleukin 6)IBA 10/2010
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2010
1	Cytokine Receptor gp130IBA 10/2010
1	Thrombopoietin (c-mpl Ligand)IBA 05/2010
1	Interleukin-8 (Interleukin 8)IBA 01/2009
1	ChemokinesIBA 01/2009
1	SmokeIBA 08/2005
1	Transcription Factors (Transcription Factor)IBA 06/2005
1	platelet-derived growth factor AIBA 02/2005
1	platelet-derived growth factor ABIBA 02/2005
1	Messenger RNA (mRNA)IBA 02/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2005

Therapy/Procedure

2	Therapeutics 01/2019 - 04/2016
1	Secondary Prevention 01/2019
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2017
1	Hysterectomy 08/2014
1	Blood Transfusion (Blood Transfusions) 08/2014
1	Stents 08/2005